Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.43 |
| ▸ | ADRB3 | P13945 | 7/20 | 0.42 |
| ▸ | ADRB1 | P08588 | 6/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CASR | P41180 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6538543 | 1.00 | BACE1 (0.43) | BACE1ADRB3ADRB1POLBCASR | |
| SCHEMBL6538478 | 0.87 | KMT2A (0.47) | BACE1ADRB3ADRB1 | |
| SCHEMBL6480871 | 0.85 | BACE1 (0.40) | BACE1ADRB3ADRB1CASRCYP2D6 | |
| SCHEMBL6480869 | 0.85 | BACE1 (0.40) | BACE1ADRB3ADRB1CASRCYP2D6 | |
| SCHEMBL6539067 | 0.85 | ADRB1 (0.49) | BACE1ADRB3ADRB1 | |
| SCHEMBL6539522 | 0.85 | ADRB1 (0.52) | BACE1ADRB3ADRB1POLB | |
| SCHEMBL6478954 | 0.82 | KMT2A (0.41) | BACE1ADRB3ADRB1CASRCYP2D6 | |
| SCHEMBL6480769 | 0.82 | RAB9A (0.41) | BACE1 | |
| SCHEMBL6479079 | 0.82 | RAB9A (0.41) | BACE1 | |
| SCHEMBL6539288 | 0.81 | ADRB1 (0.44) | BACE1ADRB3ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6826033-B2 | BETA 3 ADRENERGIC RECEPTOR AGONISTS; TREATMENT OF POLLAKIURIA, URINARY INCONTINENCE, OBESITY OR DIABETES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-11-30 | — | — | US | disclosed |
| US-20040037022-A1 | Aminoalcohol derivatives | ASTELLAS PHARMA INC. (JP) | 2004-02-26 | — | — | US | disclosed |